Strm.Bio
UEI: L64LC4L45N55
• CAGE: 8J2B6
Overview
Awardee Type
Parent
Federal Capability Statement
STRM.BIO is developing cell-based nanoparticles (exosomes) that naturally home to and fuse with hematopoietic stem cells (HSCs) in the bone marrow to deliver gene therapies.
Website
Headquarters
Cambridge, MA
United States
United States
Most Recent Award
Sept. 16, 2025
Calculating
Federal grant recipient
STRM.BIO INCORPORATED
(UEI L64LC4L45N55, CAGE 8J2B6)
is headquartered in Cambridge MA.
Its primary registered NAICS is 541713 Research and Development in Nanotechnology.
The corporation
was founded in October 2019 and
federally registered in
March 2020.
Federal Award Analysis
Strm.Bio federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
STRM.BIO INCORPORATED
UEI
L64LC4L45N55
CAGE Code
8J2B6
Primary NAICS
SBA Certifications
None
Self Certifications
For Profit Organization
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Oct. 23, 2019
Initial Registration
March 12, 2020
Last Registration
Oct. 15, 2024
Registration Activation
Oct. 15, 2024
Registration Expiration
Oct. 3, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Reported NAICS
Accepts Credit Cards
Yes